text Therapeutics (CNTX) - 2023 Q2 - Quarterly Report

For the quarterly period ended June 30, 2023 Commission file number: 001-40654 | --- | --- | --- | |------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|-------------------------------------| | Delaware | (Exact name of registrant as specified in its charter) ___________________________________ | 86-3738787 | | (State of other jurisdiction of incorporation or organization) | (I.R.S. | Emplo ...